Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Li, Haiying ^a   Sun, Liangliang ^a   Tang, Zhongping ^a   Fu, Lin ^a   Xu, Ying ^a   Li, Zixuan ^a   Luo, Wenting ^a   Qiu, Xueshan ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; PROTEIN P27; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION INTERMEDIARY FACTOR 1 ALPHA; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYCLINE; P27 ANTIGEN; TRIM24 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL LINE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; WESTERN BLOTTING; CANCER INVASION; CELL PROLIFERATION; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLINS; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 84861650468     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037657     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics. CA Cancer J Clin 60 (5): 277-300.
2. Minna JD, Roth JA, Gazdar AF, (2002) Focus on lung cancer. Cancer Cell 1 (1): 49-52.
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346 (2): 92-8.
4. Hunter K, Welch DR, Liu ET, (2003) Genetic background is an important determinant of metastatic potential. Nat Genet 34(1): 23-4; author reply 25.
5. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 (6): 453-8.
6. Le Douarin B, Nielsen AL, Garnier JM, Ichinose H, Jeanmougin F, et al. (1996) A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J 15 (23): 6701-15.
7. Le Douarin B, Nielsen AL, You J, Chambon P, Losson R, (1997) TIF1 alpha: a chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors? Biochem Soc Trans 25 (2): 605-12.
8. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, et al. (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14 (9): 2020-33.
9. Klugbauer S, Rabes HM, (1999) The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 18 (30): 4388-93.
10. Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, et al. (1999) A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat Genet 23 (3): 287-95.
11. Belloni E, Trubia M, Gasparini P, Micucci C, Tapinassi C, et al. (2005) 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosomes Cancer 42 (3): 320-5.
12. Allton K, Jain AK, Herz HM, Tsai WW, Jung SY, et al. (2009) Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci U S A 106 (28): 11612-6.
13. Katzenellenbogen BS, (1996) Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 54 (2): 287-93.
14. Tsai WW, Wang Z, Yiu TT, Akdemir KC, Xia W, et al. (2010) TRIM24 links a non-canonical histone signature to breast cancer. Nature 468 (7326): 927-32.
15. Chambon M, Orsetti B, Berthe ML, Bascoul-Mollevi C, Rodriguez C, et al. (2011) Prognostic significance of TRIM24/TIF-1alpha gene expression in breast cancer. Am J Pathol 178 (4): 1461-9.
16. Herquel B, Ouararhni K, Khetchoumian K, Ignat M, Teletin M, et al. (2011) Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci U S A 108 (20): 8212-7.
17. Ignat M, Teletin M, Tisserand J, Khetchoumian K, Dennefeld C, et al. (2008) Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alpha. Proc Natl Acad Sci U S A 105 (7): 2598-603.
18. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES, (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25 (11): 1620-8.
19. Roy PG, Thompson AM, (2006) Cyclin D1 and breast cancer. Breast 15 (6): 718-27.
20. Ratschiller D, Heighway J, Gugger M, Kappeler A, Pirnia F, et al. (2003) Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol 21 (11): 2085-93.
21. Keum JS, Kong G, Yang SC, Shin DH, Park SS, et al. (1999) Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer 81 (1): 127-32.
22. Yam CH, Fung TK, Poon RY, (2002) Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 59 (8): 1317-26.
23. D'Angiolella V, Grieco D, (2004) Attach first, then detach: a role for cyclin B-dependent kinase 1 in coordinating proteolysis with spindle assembly. Cell Cycle 3 (2): 132-3.
24. Lee J, Kim SS, (2009) The function of p27 KIP1 during tumor development. Exp Mol Med 41 (11): 765-71.
25. Chu IM, Hengst L, Slingerland JM, (2008) The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8 (4): 253-67.
26. Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, et al. (2005) Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res 11 (1): 232-41.
27. Hayashi H, Ogawa N, Ishiwa N, Yazawa T, Inayama Y, et al. (2001) High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients. Lung Cancer 34 (1): 59-65.
28. Inui N, Sasaki S, Suda T, Chida K, Nakamura H, (2003) The loss of retinoic acid receptor alpha, beta and alcohol dehydrogenase3 expression in non-small cell lung cancer. Respirology 8 (3): 302-9.